David Hong
Analyst
Deutsche Bank
Equibles does not estimate personal net worth.
About David Hong
David Hong is recorded as Analyst at Deutsche Bank. David Hong has spoken on 4 earnings calls across 3 companies, most recently for Alkermes plc. on November 3, 2026. Those appearances were for Jazz Pharmaceuticals plc (JAZZ), Alkermes plc. (ALKS) and Axsome Therapeutics, Inc. (AXSM). The companies whose calls David Hong spoke on are classified in the Healthcare sector.
David Hong on recent calls
“I wanted to ask, once you are post Vibrance III data in IH, either year-end or early 27, once that data is in hand, How quickly would you look to move into a Phase III program for IH, and what would that study design potentially look like?”
“I wanted to drill down a little bit on the commentary about the threefold increase, I believe, in ordering accounts in September for ZIERA that you're seeing. How should we think about that step up in accounts translating over to revenues, and what would be the timeframe that that would occur in?”
“So, first, I wanted to come back to the peak sales number that you put out there for Avelity. If I heard you correctly, I think you said 50-50 for the, you know, MDD versus ADA indications.”
“So maybe a follow-up to some of the questions here on the Sleep-Wake franchise. Just in terms of your payer contracts, you mentioned that you feel confident about the ones you have in place.”
Affiliation history
-
Deutsche Bank
Analyst
Transcript header (unverified)
Current
Company network
Alkermes plc.
ALKS
Drug Manufacturers - Specialty & Generic · Healthcare
1 appearance
Latest appearance 2026-11-03
View calls and events